how to stop taking tirzepatide When Tirzepatide: A Complete Transition Guide How to Wean Off Mounjaro:

If 8 mg produces consistent weight loss with good tolerability, it is an excellent maintenance dose

If you snore heavily, wake unrefreshed, or feel sleepy during the day, its worth asking your GP about a sleep study

Week 5-8: Low therapeutic dose (5mg) Weekly dose : 5mg (double from 2.5mg) Why this dose : First therapeutic dose Noticeable appetite suppression Steady weight loss begins Side effects still manageable What to expect : Moderate appetite suppression (40-50%) Consistent 1-2 lb weekly loss Nausea reduces (if present initially) Energy normalizes Total weight loss so far : 6-10 lbs Week 9-12: Medium dose (7.5mg) Weekly dose : 7.5mg Why this dose : Increased effectiveness Strong appetite control Accelerated fat loss Still tolerable for most What to expect : Strong appetite suppression (60-70%) 1.5-2 lbs weekly loss Minimal side effects (body adapted) Improved insulin sensitivity Total weight loss so far : 12-18 lbs Week 13-16: High therapeutic dose (10mg) Weekly dose : 10mg Why this dose : Maintenance dose for many users Maximum appetite suppression Optimal metabolic effects Sustainable long-term What to expect : Very strong appetite control (70-80%) Continued 1-2 lb weekly loss Minimal hunger most days Excellent insulin control Total weight loss so far : 18-26 lbs Week 17-20: Maximum dose (12.5-15mg) Weekly dose : 12.5mg or 15mg (optional) Why this dose : For those who plateau at 10mg Additional 3-5% weight loss Maximum therapeutic effect Not needed by everyone What to expect : Maximum suppression (80-90%) Final 5-10 lbs to goal Very little hunger Excellent metabolic health Total weight loss (20 weeks) : 25-35 lbs average Note : Many people maintain at 10mg

It represents a fundamentally different approach to metabolic intervention, one that addresses energy expenditure in addition to energy intake

The most exciting clinical takeaway is the steadiness of the control

Similarly, if this patient were to stop smoking and her systolic BP improved to 133 mm Hg at her 3- to 6-month follow-up visit, her updated 10-year CVD risk would decrease from 9.2% to 5.7%